Related Experiment Video
Updated: Jun 6, 2025

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis
Shanshan Yang1, Miaomiao Lin1, Shaodong Hao2
1Traditional Chinese Medicine and Integrative Medicine Department, Peking University First Hospital, Beijing, China.
Metabolic reprogramming (MR) in cancer (CA) research has rapidly expanded, revealing key trends and influential contributors. This bibliometric analysis highlights the growing scientific output and emerging focus areas in understanding and targeting cancer metabolism.
Area of Science:
- Oncology
- Metabolism
- Bibliometrics
Background:
- Metabolic reprogramming (MR) in cancer (CA) is a critical research area with significant therapeutic implications.
- Understanding the intellectual landscape of MR/CA research is essential for identifying future directions.
Purpose of the Study:
- To conduct a bibliometric analysis of MR/CA research.
- To assess scientific output, identify major contributors, and map research trends.
Main Methods:
- Systematic literature search on Web of Science (2006-2023).
- Bibliometric analysis using Biblioshiny, VOSviewer, and Excel.
- Co-citation analysis to map conceptual structure and influential publications.
Main Results:
- 4,465 publications identified, with rapid growth from 2006-2023.
- China and the US lead in publications; key journals include *Frontiers in Oncology* and *Cell Metabolism*.
- Emerging topics include tumor microenvironment, lipid metabolism, non-coding RNAs, exosomes, and immunotherapy.
Conclusions:
- This study provides a quantitative overview of MR/CA research.
- Identified key publications, institutions, and authors, outlining current status and evolving trends.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...